Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
21.08
+0.42 (2.03%)
Aug 5, 2026, 4:00 PM EDT - Market closed
Sabra Health Care REIT Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 65.23 | 155.51 | 126.71 | 13.76 | -77.61 | -113.26 |
Depreciation & Amortization | 209.43 | 187 | 169.62 | 183.09 | 187.78 | 178.99 |
Stock-Based Compensation | 13.13 | 11.36 | 8.99 | 7.92 | 7.45 | 7.91 |
Other Adjustments | 91.74 | 4.6 | 27.77 | 98.55 | 217.8 | 260.04 |
Change in Receivables | -16.5 | -11.45 | -15.46 | -11.08 | -6.44 | 8.22 |
Changes in Accounts Payable | 7.81 | 1.6 | -7.09 | 8.34 | -13.25 | 14.48 |
Operating Cash Flow | 371.57 | 348.61 | 310.54 | 300.57 | 315.73 | 356.39 |
Operating Cash Flow Growth | 9.66% | 12.26% | 3.32% | -4.80% | -11.41% | 1261.20% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -737.44 | -494.45 | -191.14 | -163.39 | -146.68 | -142.1 |
Sale of Property, Plant & Equipment | 178.67 | 88.64 | 96 | 247.62 | 87.3 | 100.72 |
Purchases of Investments | -5.46 | -6.92 | -24.48 | -22.44 | -31.83 | -299.06 |
Proceeds from Sale of Investments | 222.21 | 23.2 | 9.5 | 14.73 | 10.65 | 4.24 |
Other Investing Activities | -0.21 | 11.57 | 1.12 | 26.6 | -135.69 | - |
Investing Cash Flow | -334.97 | -377.96 | -109 | 103.13 | -216.25 | -336.2 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | 155.46 | 109.81 | 14.6 | -104.34 | 204.05 | - |
Net Short-Term Debt Issued (Repaid) | 155.46 | 109.81 | 14.6 | -104.34 | 204.05 | - |
Long-Term Debt Issued | - | 500 | - | 12.19 | - | 791.52 |
Long-Term Debt Repaid | -2.12 | -502.09 | -2.03 | -1.98 | -81.27 | -767.66 |
Net Long-Term Debt Issued (Repaid) | -2.12 | -2.09 | -2.03 | 10.21 | -81.27 | 23.86 |
Issuance of Common Stock | 251.28 | 227.78 | 86.12 | -2.68 | -4.81 | 308.71 |
Net Common Stock Issued (Repurchased) | 251.28 | 227.78 | 86.12 | -2.68 | -4.81 | 308.71 |
Common Dividends Paid | -298.06 | -289.5 | -280.15 | -277.45 | -277.16 | -262.92 |
Other Financing Activities | -5.59 | -7.29 | 1.95 | -36.04 | -2.52 | -39.51 |
Financing Cash Flow | 100.01 | 40.76 | -181.56 | -410.3 | -161.71 | 30.14 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.08 | 0.39 | -0.36 | -0.61 | 0.27 | 0.03 |
Net Cash Flow | 136.61 | 11.41 | 19.98 | -6.6 | -62.22 | 50.33 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -365.86 | -145.84 | 119.4 | 137.19 | 169.06 | 214.29 |
Free Cash Flow Growth | - | - | -12.97% | -18.85% | -21.11% | 1403.37% |
FCF Margin | -44.59% | -19.95% | 17.93% | 22.40% | 28.79% | 38.80% |
Free Cash Flow Per Share | -1.46 | -0.60 | 0.51 | 0.59 | 0.73 | 0.98 |
Levered Free Cash Flow | -301.42 | -42.54 | 110.67 | -52.33 | 73.03 | -38.03 |
Unlevered Free Cash Flow | -406.1 | -95.42 | 171.21 | 178.27 | 132.64 | 238.35 |